These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 17045835
1. Interleukin-6 trans-signaling in inflammatory bowel disease. Mitsuyama K, Sata M, Rose-John S. Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835 [Abstract] [Full Text] [Related]
2. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M. Anticancer Res; 2007 Dec; 27(6A):3749-56. PubMed ID: 17970038 [Abstract] [Full Text] [Related]
3. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S, Scheller J, Elson G, Jones SA. J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558 [Abstract] [Full Text] [Related]
4. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T. J Immunol; 2010 Feb 01; 184(3):1543-51. PubMed ID: 20042582 [Abstract] [Full Text] [Related]
7. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF. Int Immunol; 2007 Jun 01; 19(6):685-93. PubMed ID: 17496315 [Abstract] [Full Text] [Related]
12. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis. Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V. J Surg Res; 2009 Dec 01; 157(2):235-42. PubMed ID: 19589542 [Abstract] [Full Text] [Related]
13. IL-6 signal transduction and its physiological roles: the signal orchestration model. Kamimura D, Ishihara K, Hirano T. Rev Physiol Biochem Pharmacol; 2003 Dec 01; 149():1-38. PubMed ID: 12687404 [Abstract] [Full Text] [Related]
14. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Li Y, Yu C, Zhu WM, Xie Y, Qi X, Li N, Li JS. Mol Immunol; 2010 Sep 01; 47(15):2467-74. PubMed ID: 20615550 [Abstract] [Full Text] [Related]
15. The soluble IL-6 receptors: serum levels and biological function. Montero-Julian FA. Cell Mol Biol (Noisy-le-grand); 2001 Jun 01; 47(4):583-97. PubMed ID: 11502067 [Abstract] [Full Text] [Related]
16. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. Eur J Cell Biol; 2011 Jun 01; 90(6-7):484-94. PubMed ID: 21145125 [Abstract] [Full Text] [Related]
17. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease. Atreya R, Atreya I, Neurath MF. Ann N Y Acad Sci; 2006 Aug 01; 1072():98-113. PubMed ID: 17057193 [Abstract] [Full Text] [Related]
18. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma. Barillé S, Bataille R, Amiot M. Eur Cytokine Netw; 2000 Dec 01; 11(4):546-51. PubMed ID: 11125296 [Abstract] [Full Text] [Related]
19. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? Reuter BK, Pizarro TT. Eur J Immunol; 2004 Sep 01; 34(9):2347-55. PubMed ID: 15307167 [Abstract] [Full Text] [Related]